Condition: Cervical Cancer · Sponsor: Chongqing University Cancer Hospital
This is a single-center single-arm study. The main purpose of this study is to study the efficacy of surgical treatment for patients with locally advanced cervical cancer (FIGO IB3, IIA2-IVA) who still have residual tumor after concurrent radiotherapy and chemotherapy.
This description comes directly from the study's public registry record.
Dongling Zou, PH.D · 13657690699 · cqzl_zdl@163.com
Dongling Zou, PH.D
Always discuss trial participation with your own doctor first.
| Chongqing Cancer Hospital | Chongqing, Chongqing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05749887